BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2999395)

  • 1. Angiotensin converting enzyme inhibitors: N-substituted D-glutamic acid gamma dipeptides.
    Ksander GM; Yuan AM; Diefenbacher CG; Stanton JL
    J Med Chem; 1985 Nov; 28(11):1606-11. PubMed ID: 2999395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting enzyme inhibitors: synthesis and structure-activity relationships of potent N-benzyloxycarbonyl tripeptide inhibitors.
    Sawayama T; Tsukamoto M; Sasagawa T; Nishimura K; Yamamoto R; Deguchi T; Takeyama K; Hosoki K
    Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2417-22. PubMed ID: 2605684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological activity of modified peptide inhibitors of angiotensin-converting enzyme.
    Roark WH; Tinney FJ; Cohen D; Essenburg AD; Kaplan HR
    J Med Chem; 1985 Sep; 28(9):1291-5. PubMed ID: 2993618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme inhibitors: synthesis and biological activity of N-substituted tripeptide inhibitors.
    Sawayama T; Tsukamoto M; Sasagawa T; Nishimura K; Deguchi T; Takeyama K; Hosoki K
    Chem Pharm Bull (Tokyo); 1990 Jan; 38(1):110-5. PubMed ID: 2159850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin converting enzyme inhibitors: 1-glutarylindoline-2-carboxylic acids derivatives.
    Gruenfeld N; Stanton JL; Yuan AM; Ebetino FH; Browne LJ; Gude C; Huebner CF
    J Med Chem; 1983 Sep; 26(9):1277-82. PubMed ID: 6310113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibitory activity of SCH 31846, a new non-sulfhydryl inhibitor.
    Sybertz EJ; Baum T; Ahn HS; Nelson S; Eynon E; Desiderio DM; Pula K; Becker F; Sabin C; Moran R; Vander Vliet G; Kastner B; Smith E
    J Cardiovasc Pharmacol; 1983; 5(4):643-54. PubMed ID: 6193364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CI-906 and CI-907: new orally active nonsulfhydryl angiotensin-converting enzyme inhibitors.
    Kaplan HR; Cohen DM; Essenburg AD; Major TC; Mertz TE; Ryan MJ
    Fed Proc; 1984 Apr; 43(5):1326-9. PubMed ID: 6323223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin converting enzyme inhibitors: N-substituted monocyclic and bicyclic amino acid derivatives.
    Stanton JL; Gruenfeld N; Babiarz JE; Ackerman MH; Friedmann RC; Yuan AM; Macchia W
    J Med Chem; 1983 Sep; 26(9):1267-77. PubMed ID: 6310112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (Mercaptopropanoyl)indoline-2-carboxylic acids and related compounds as potent angiotensin converting enzyme inhibitors and antihypertensive agents.
    Kim DH; Guinosso CJ; Buzby GC; Herbst DR; McCaully RJ; Wicks TC; Wendt RL
    J Med Chem; 1983 Mar; 26(3):394-403. PubMed ID: 6298429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible involvement of ATP-dependent K-channel related mechanisms in the antihypertensive and cough suppressant effects of the novel ACE inhibitor (2S, 3aS, 7aS)-1-(N2-nicotinoyl-L-lysyl-gamma-D-glutamyl)octahydro-1H- indole-2-carboxylic acid.
    Nagata S; Takeyama K; Hosoki K; Karasawa T
    Arzneimittelforschung; 1997 Jun; 47(6):726-30. PubMed ID: 9239450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive properties of a new long-acting angiotensin converting enzyme inhibitor in renin-dependent and independent hypertensive models.
    Nagata S; Takeyama K; Fukuya F; Nagai R; Hosoki K; Nishimura K; Deguchi T; Karasawa T
    Arzneimittelforschung; 1995 Aug; 45(8):853-8. PubMed ID: 7575746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New alpha-thiol dipeptide dual inhibitors of angiotensin-I converting enzyme and neutral endopeptidase EC 3.4.24.11.
    Fink CA; Qiao Y; Berry CJ; Sakane Y; Ghai RD; Trapani AJ
    J Med Chem; 1995 Dec; 38(26):5023-30. PubMed ID: 8544178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Derivatives of the potent angiotensin converting enzyme inhibitor 5(S)-benzamido-4-oxo-6-phenylhexanoyl-L-proline: effect of changes at positions 2 and 5 of the hexanoic acid portion.
    Almquist RG; Crase J; Jennings-White C; Meyer RF; Hoefle ML; Smith RD; Essenburg AD; Kaplan HR
    J Med Chem; 1982 Nov; 25(11):1292-9. PubMed ID: 6292422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and angiotensin converting enzyme inhibitory activity of N-carboxymethyldipeptides with omega-(4-piperidyl)alkyl group.
    Waga T; Matsui S; Saito S; Watanabe M; Kajiwara Y; Shirota M; Iijima M; Kitabatake K
    Arzneimittelforschung; 1990 Apr; 40(4):407-13. PubMed ID: 2162675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mercaptoacyl dipeptides as orally active dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase.
    Fink CA; Carlson JE; McTaggart PA; Qiao Y; Webb R; Chatelain R; Jeng AY; Trapani AJ
    J Med Chem; 1996 Aug; 39(16):3158-68. PubMed ID: 8759637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (Phosphinyloxy)acyl amino acid inhibitors of angiotensin converting enzyme. 2. Terminal amino acid analogues of (S)-1-[6-amino-2 [[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]-L-proline.
    Karanewsky DS; Badia MC; Cushman DW; DeForrest JM; Dejneka T; Lee VG; Loots MJ; Petrillo EW
    J Med Chem; 1990 May; 33(5):1459-69. PubMed ID: 2329568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin converting enzyme inhibitors: 1,5-benzothiazepine derivatives.
    Slade J; Stanton JL; Ben-David D; Mazzenga GC
    J Med Chem; 1985 Oct; 28(10):1517-21. PubMed ID: 2995670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on angiotensin converting enzyme inhibitors. 4. Synthesis and angiotensin converting enzyme inhibitory activities of 3-acyl-1-alkyl-2-oxoimidazolidine-4-carboxylic acid derivatives.
    Hayashi K; Nunami K; Kato J; Yoneda N; Kubo M; Ochiai T; Ishida R
    J Med Chem; 1989 Feb; 32(2):289-97. PubMed ID: 2913292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.
    Gross DM; Sweet CS; Ulm EH; Backlund EP; Morris AA; Weitz D; Bohn DL; Wenger HC; Vassil TC; Stone CA
    J Pharmacol Exp Ther; 1981 Mar; 216(3):552-7. PubMed ID: 6259322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel synthesis of (S)-1-[5-(benzoylamino)-1,4-dioxo-6-phenylhexyl]-L-proline and analogues: potent angiotensin converting enzyme inhibitors.
    Meyer RF; Nicolaides ED; Tinney FJ; Lunney EA; Holmes A; Hoefle ML; Smith RD; Essenburg AD; Kaplan HR; Almquist RG
    J Med Chem; 1981 Aug; 24(8):964-9. PubMed ID: 6173481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.